Thus, we conclude that soluble P-selectin may offer new perspectives for preventing P-selectin-mediated platelet deposition within solid tumors, and targeting this newly identified platelet-cancer cell interaction potentially represents a novel effective therapeutic approach to human cancer treatment. The gene discussed is SELP; the disease is cancer.